Heber Rew Bright Bright

8PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Infectious diseasesNaturopathyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 15, 2026
Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data.

|May 04, 2026
Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

|Oct 31, 2025
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised Evidence.

Heber Rew Bright Bright, Duc Binh Phan, Amna Zahid

|Oct 09, 2024
Facilitators, Barriers, and Potential Impacts of Implementation of e-Pharmacy in India and its Potential Impact on Cost, Quality, and Access to Medicines: Scoping Review.

Aditi Apte, Heber Rew Bright, Sandeep Kadam

|Jun 21, 2024
Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting.

Heber Rew Bright, Ashish Singh, Anjana Joel

Pageof 2

Frequent Collaborators

6 joint publications

Zenas Z N Yiu

5 joint publications

Richard B Warren

5 joint publications

Philip Laws

2 joint publications

Sujith J Chandy